Vietnam Opioid Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Vietnam Opioid Market Overview

• The Vietnam Opioid Market is valued at USD 1.1 billion, based on a five-year historical analysis of prescription drugs and controlled medicines within the broader Vietnam pharmaceuticals market, which itself has been valued in the mid?single?digit billion range in recent years. This growth is primarily driven by the increasing prevalence of chronic pain conditions and cancer, alongside rising demand for effective pain management solutions and controlled analgesics. The market is also supported by expanding healthcare infrastructure, greater access to hospital?based care, and growing use of prescription medicines in clinical settings, particularly in urban and tertiary hospitals.
• Key cities dominating the market include Ho Chi Minh City and Hanoi, which are the largest urban centers in Vietnam and act as primary hubs for the country’s pharmaceutical and hospital markets. These cities have a higher concentration of central and provincial hospitals, oncology centers, and private clinics, creating stronger demand for pain management therapies, including opioids, and ensuring higher consumption of prescription medicines. Additionally, the presence of leading domestic manufacturers, importers, and distributors in southern Vietnam and Hanoi supports robust supply chains and enhances market growth for controlled drugs.
• Opioid prescription, distribution, and use in Vietnam are governed by a strict controlled?substances framework, particularly Decree No. 105/2021/ND-CP on management of narcotic substances and precursors issued by the Government of Vietnam, which details licensing, storage, record?keeping, and reporting obligations for medical facilities handling narcotic medicines including opioids. The regulation requires prescribing physicians and dispensing facilities to comply with standardized prescription forms, quantity limits, and documentation procedures and mandates monitoring of narcotic drug imports, distribution, and use through centralized reporting managed by competent health and drug?control authorities. In parallel, Ministry of Health circulars on narcotic and psychotropic medicines provide detailed professional and training requirements for prescribers and pharmacists involved in opioid?based pain management and substitution therapy.

Vietnam Opioid Market Segmentation

By Drug Type:The opioid market can be segmented into four main drug types: natural opioids, semi-synthetic opioids, synthetic opioids, and combination formulations. Natural opioids, such as morphine and codeine, are derived from the opium poppy and are widely used for moderate to severe pain relief, especially in hospital and oncology settings. Semi-synthetic opioids, including oxycodone and hydrocodone, are modified versions of natural opioids and are commonly used internationally for moderate to severe pain, though in Vietnam their use is more restricted and concentrated in hospital settings where stronger analgesia is needed. Synthetic opioids, like fentanyl, methadone, and tramadol, are entirely man-made and are known for their potency and flexibility in dosage forms; tramadol and fentanyl are important components of pain management, while methadone is central to opioid substitution therapy programs in Vietnam. Combination formulations typically include a mix of weak opioids such as codeine or tramadol with non-opioid analgesics (for example, paracetamol) to enhance pain relief for acute and moderate pain while aiming to limit opioid dose. Within this structure, synthetic opioids and tramadol?based products have seen particularly strong uptake due to their clinical effectiveness, availability in multiple dosage strengths, and their use across both hospital and outpatient settings.

By Application:The opioid market is segmented based on applications, including cancer pain management, post-operative and acute pain management, chronic non-cancer pain management, opioid dependence/substitution therapy, and others. Cancer pain management is a significant segment due to the increasing incidence and prevalence of cancer in Vietnam and the emphasis on integrating morphine and other strong opioids into palliative and end?of?life care. Post-operative and acute pain management is also crucial, as surgical volumes are rising with the expansion of public and private hospital capacity and wider access to elective procedures, necessitating short?term opioid use in inpatient settings. Chronic non-cancer pain management is gaining traction as awareness of musculoskeletal disorders, neuropathic pain, and other long-term conditions increases, although guidelines promote careful benefit–risk assessment and use of multimodal pain strategies. Opioid dependence/substitution therapy, particularly through methadone maintenance treatment programs supported by the Ministry of Health and international partners, plays a central role in addressing heroin and other opioid use disorders and has been scaled up across many provinces. Currently, cancer pain management and hospital-based acute pain remain core application areas in terms of opioid volume, supported by the growing cancer patient population and continued strengthening of tertiary care services.

Vietnam Opioid Market Competitive Landscape

The Vietnam Opioid Market is characterized by a dynamic mix of regional and international players. Leading participants such as Vietnam Pharmaceutical Corporation (VINAPHARM), DHG Pharmaceutical JSC (Hau Giang Pharmaceutical), Domesco Medical Import-Export JSC, Traphaco JSC, Bidiphar JSC (Binh Dinh Pharmaceutical), Central Pharmaceutical Company No. 1 (CPC1), Vimedimex Medi-Pharma JSC, S.P.M JSC (SPM Pharmaceutical), Imexpharm Corporation, OPC Pharmaceutical JSC, Mekophar Chemical Pharmaceutical JSC, Pymepharco JSC, Savipharm JSC, Boston Pharma JSC, Bepharco (Ben Tre Pharmaceutical JSC) contribute to innovation, geographic expansion, and service delivery in this space.

Vietnam Opioid Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Chronic Pain:The Vietnam healthcare system reports that approximately 30% of the population suffers from chronic pain conditions, translating to around 26 million individuals. This rising prevalence is driving the demand for effective pain management solutions, including opioids. The World Health Organization estimates that chronic pain affects about 20% of adults globally, indicating a significant need for opioid therapies in Vietnam, particularly as the population ages and lifestyle diseases become more common.
• Rising Demand for Palliative Care:Vietnam's aging population, projected to reach 20% in the coming years, is increasing the demand for palliative care services. In future, the Ministry of Health aims to expand palliative care programs, which currently serve only 5% of patients in need. This expansion is crucial as it aligns with the global trend of integrating opioids into palliative care, ensuring that patients receive adequate pain relief during end-of-life care, thus driving opioid market growth.
• Expanding Healthcare Infrastructure:Vietnam's healthcare expenditure is expected to reach $22 billion in future, reflecting a 10% increase from previous years. This investment is aimed at enhancing healthcare facilities and services, particularly in urban areas. Improved access to healthcare services facilitates better pain management practices, including opioid prescriptions. The government’s commitment to healthcare infrastructure development is essential for meeting the growing demand for opioid therapies in the country.

Market Challenges

• Regulatory Restrictions on Opioid Prescriptions:Vietnam has stringent regulations governing opioid prescriptions, with only 0.5% of patients receiving opioids for chronic pain management. These regulations are primarily due to concerns over misuse and addiction. The Ministry of Health is working to balance patient needs with regulatory frameworks, but the current restrictions hinder access to necessary pain relief for many patients, limiting market growth potential.
• Stigma Associated with Opioid Use:There is a significant stigma surrounding opioid use in Vietnam, with many healthcare providers and patients fearing addiction. This stigma results in under-prescription of opioids, with only 12% of healthcare professionals feeling comfortable prescribing them for chronic pain. Educational initiatives are needed to address misconceptions and promote responsible opioid use, as overcoming this stigma is crucial for expanding the market and improving patient outcomes.

Vietnam Opioid Market Future Outlook

The Vietnam opioid market is poised for transformation as healthcare policies evolve to address pain management more effectively. With a focus on integrating technology and personalized medicine, the market is likely to see innovative opioid formulations and telemedicine solutions emerge in future. Additionally, increased collaboration between healthcare providers and educational initiatives will enhance awareness of pain management options, ultimately improving patient access to necessary treatments and fostering a more supportive environment for opioid use.

Market Opportunities

• Development of New Opioid Formulations:There is a significant opportunity for pharmaceutical companies to develop new opioid formulations that minimize addiction risks while providing effective pain relief. Innovations such as abuse-deterrent formulations can cater to the growing demand for safer pain management options, potentially increasing market share and improving patient outcomes.
• Expansion of Telemedicine for Pain Management:The rise of telemedicine presents a unique opportunity to enhance access to pain management services, particularly in rural areas. By leveraging technology, healthcare providers can offer consultations and prescriptions remotely, addressing the barriers posed by limited access to healthcare facilities and improving patient adherence to pain management regimens.